Endolymphatic space imaging in idiopathic sudden sensorineural hearing loss with vertigo

Abstract

The results of the study imply that there may be some relationship between endolymphatic hydrops and ISNHL with vertigo.

Endolymphatic Hydrops Revealed by Magnetic Resonance Imaging in Patients With Acute Low-Tone Sensorineural Hearing Loss

“…Twelve cases of 25 in the present case series met the diagnostic criteria of SD as well, and they are considered as SD confined to low tone. A MRI study also reported that EH was recognized in the cochlea and/or the vestibule in 4 of 7 ears with SD accompanying vertigo (26). It was reported that cochlear and vestibular EH were seen in 4 of 11 ears with SD in the temporal bone study (25).…”

Visualization of endolymphatic hydrops with MR imaging in patients with Ménière’s disease and related pathologies: current status of its methods and clinical significance

“…In cases of sudden deafness and vertigo, more than half of the patients showed endolymphatic hydrops in the cochlea and/or the vestibule of the affected ears. Thus, there may be some relationship between endolymphatic hydrops and idiopathic sensorineural hearing loss with vertigo [3].…”

“…Endolymphatic hydrops has long been held to be the pathological basis for Ménière's disease [1,2]. Some patients have inner ear symptoms that do not match the diagnostic guidelines for Ménière's disease, and these are also thought to be related to endolymphatic hydrops [3][4][5][6]. Endolymphatic hydrops is a pathological anatomical finding in which the structures bounding the endolymphatic space are distended by an enlargement of endolymphatic volume.…”

Semi-quantification of Endolymphatic Size on MR Imaging after Intravenous Injection of Single-dose Gadodiamide: Comparison between Two Types of Processing Strategies

“…Disease in some patients with inner ear symptoms that do not match the diagnostic guideline of M áeni àere's disease is also believed to be based on endolymphatic hydrops. [3][4][5][6] Endolymphatic hydrops wasˆrst visualized in patients with M áeni àere's disease by MR imaging us-ing 3-dimensional (3D) ‰uid-attenuated inversion recovery (FLAIR) obtained 24 hours after intratympanic (IT) administration of gadoliniumbased contrast material (GBCM). 7 However, this use of GBCM is oŠ-label and requires 24 hours of waiting time and puncture of the tympanic membrane.…”